X0508 4 2024-02-12 0001228627 Ocuphire Pharma, Inc. OCUP 0002008983 Jayagopal Ashwath C/O OCUPHIRE PHARMA, INC. 37000 GRAND RIVER AVE, SUITE 120 FARMINGTON HILLS MI 48335 true Chief Scientific & Dev. Ofc. false Common Stock 2024-02-12 4 A 0 75000 0 A 75000 D Employee Stock Option (right to buy) 2.66 2024-02-12 4 A 0 225000 0 A 2034-02-11 Common Stock 225000 225000 D Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of February 12, 2024, subject to the Reporting Person's continuing service. The option will vest with respect to 25% on February 12, 2025, with the remaining shares vesting quarterly in 12 equal installments thereafter, subject to the Reporting Person's continuing service. /s/ Amy Rabourn, by Power of Attorney 2024-02-14